BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30939952)

  • 1. Correlation and concordance measures between clinical, endoscopic and histological scores activity in Crohn's disease under treatment.
    Tajra JB; Calegaro JU; de Paula AP; Bachour D; Silveira D; Lozi M; Cavalcanti H
    Scand J Gastroenterol; 2019 Apr; 54(4):441-445. PubMed ID: 30939952
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between endoscopic and histological validated scoring indices in Crohn's disease.
    Gong W; Guo K; Zheng T; Fang M; Xie H; Li W; Hong Z; Ren H; Gu G; Wang G; Wu X; Wang Z; Ren J; Li J
    Dig Liver Dis; 2019 Jun; 51(6):812-817. PubMed ID: 30718202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.
    Löwenberg M; Vermeire S; Mostafavi N; Hoentjen F; Franchimont D; Bossuyt P; Hindryckx P; Rispens T; de Vries A; van der Woude CJ; Berends S; Ambarus CA; Mathot R; Clasquin E; Baert F; D'Haens G
    Gastroenterology; 2019 Oct; 157(4):997-1006.e6. PubMed ID: 31175865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
    Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
    Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
    Geboes K; Rutgeerts P; Opdenakker G; Olson A; Patel K; Wagner CL; Marano CW
    Curr Med Res Opin; 2005 Nov; 21(11):1741-54. PubMed ID: 16307694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Turunen U; Arkkila P; Sipponen T; Färkkilä M
    Scand J Gastroenterol; 2012 May; 47(5):528-37. PubMed ID: 22356594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML
    BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive enteral nutrition induces early clinical, mucosal and transmural remission in paediatric Crohn's disease.
    Grover Z; Muir R; Lewindon P
    J Gastroenterol; 2014 Apr; 49(4):638-45. PubMed ID: 23636735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
    Lewis JD; Rutgeerts P; Feagan BG; D'haens G; Danese S; Colombel JF; Reinisch W; Rubin DT; Selinger C; Bewtra M; Barcomb L; Lacerda AP; Wallace K; Butler JW; Wu M; Zhou Q; Liao X; Sandborn WJ
    Inflamm Bowel Dis; 2020 Jan; 26(2):304-313. PubMed ID: 31644790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial.
    Peyrin-Biroulet L; Reinisch W; Colombel JF; Mantzaris GJ; Kornbluth A; Diamond R; Rutgeerts P; Tang LK; Cornillie FJ; Sandborn WJ
    Gut; 2014 Jan; 63(1):88-95. PubMed ID: 23974954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.
    Eder P; Katulska K; Lykowska-Szuber L; Stawczyk-Eder K; Krela-Kaźmierczak I; Linke K
    Pol Arch Med Wewn; 2013; 123(7-8):378-85. PubMed ID: 23778300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD.
    Sipponen T; Nuutinen H; Turunen U; Färkkilä M
    Inflamm Bowel Dis; 2010 Dec; 16(12):2131-6. PubMed ID: 20848462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological Indices and Risk of Recurrence in Crohn's Disease: A Retrospective Study of a Cohort of Patients in Endoscopic Remission.
    Marion L; Amélie B; Zoubir D; Guillaume C; Elise MS; Hedia B; Margaux LS; Aude M; Camille BR
    Inflamm Bowel Dis; 2022 Sep; 28(9):1395-1404. PubMed ID: 35429159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD.
    Daperno M; D'Haens G; Van Assche G; Baert F; Bulois P; Maunoury V; Sostegni R; Rocca R; Pera A; Gevers A; Mary JY; Colombel JF; Rutgeerts P
    Gastrointest Endosc; 2004 Oct; 60(4):505-12. PubMed ID: 15472670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.